Selective expression of osteopontin in ALS-resistant motor neurons is a critical determinant of late phase neurodegeneration mediated by matrix metalloproteinase-9

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Morisaki, Yuta ^a   Niikura, Mamiko ^a   Watanabe, Mizuho ^a   Onishi, Kosuke ^a   Tanabe, Shogo ^a   Moriwaki, Yasuhiro ^a   Okuda, Takashi ^a   Ohara, Shinji ^b   Murayama, Shigeo ^c   Takao, Masaki ^c   Uchida, Sae ^c   Yamanaka, Koji ^d   Misawa, Hidemi ^a  

^a KEIO UNIVERSITY   (Japan)

^b National Hospital Organization Matsumoto Medical Center Matsumoto Hospital   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^d NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; OSTEOPONTIN; SPP1 PROTEIN, HUMAN; SPP1 PROTEIN, MOUSE; VITRONECTIN RECEPTOR;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL; DISEASE MODEL; HUMAN; METABOLISM; MOTONEURON; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; INTEGRIN ALPHAVBETA3; MATRIX METALLOPROTEINASE 9; MICE; MOTOR NEURONS; OSTEOPONTIN;

EID: 84974784742     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep27354     Document Type: Article

References (65)

1. Kanning, K. C., Kaplan, A., & Henderson, C. E. Motor neuron diversity in development and disease. Annu. Rev. Neurosci. 33, 409-440 (2010
2. Comley, L., et al. Motor neurons with differential vulnerability to degeneration show distinct protein signatures in health and ALS. Neuroscience 291, 216-229 (2015
3. Friese, A., Kaltschmidt, J. A., Ladle, D. R., Sigrist, M., & Jessell, T. M. Gamma and alpha motor neurons distinguished by expression of transcription factor Err3. Proc. Natl. Acad. Sci. USA 106, 13588-13593 (2009
4. Schneider, N. A., Brown, M. N., Smith, C. A., Pickel, J., & Alvarez, F. J. Gamma motor neurons express distinct genetic markers at birth and require muscle spindle-derived GDNF for postnatal survival. Neural Dev. 4, 42 (2009
5. Chakkalakal, J. V., Nishimune, H., Ruas, J. L., Spiegelman, B. M., & Sanes, J. R. Retrograde influence of muscle fibers on their innervation revealed by a novel marker for slow motoneurons. Development 137, 3489-3499 (2010
6. Enjin, A., et al. Identification of novel spinal cholinergic genetic subtypes disclose Chodl and Pitx2 as markers for fast motor neurons and partition cells. J. Comp. Neurol. 518, 2284-2304 (2010
7. Renton, A. E., Chi?, A., & Traynor, B. J. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 17, 17-23 (2014
8. Turner, B. J., & Talbot, K. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog. Neurobiol. 85, 94-134 (2008
9. Hegedus, J., Putman, C. T., & Gordon, T. Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 28, 154-164 (2007
10. Rocha, M. C., Pousinha, P. A., Correia, A. M., Sebastião, A. M., & Ribeiro, J. A. Early changes of neuromuscular transmission in the SOD1(G93A) mice model of ALS start long before motor symptoms onset. PLoS One 8, e73846 (2013
11. Frey, D., et al. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci. 20, 2534-2542 (2000
12. Pun, S., Santos, A. F., Saxena, S., Xu, L., & Caroni, P. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat. Neurosci. 9, 408-419 (2006
13. Schaefer, A. M., Sanes, J. R., & Lichtman, J. W. A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis. J. Comp. Neurol. 490, 209-219 (2005
14. Saxena, S., et al. Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival. Neuron 80, 80-96 (2013
15. Ilieva, H., Polymenidou, M., & Cleveland, D. W. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell Biol. 187, 761-772 (2009
16. Komine, O., & Yamanaka, K. Neuroinflammation in motor neuron disease. Nagoya J. Med. Sci. 77, 537-549 (2015
17. Urushitani, M., et al. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat. Neurosci. 9, 108-118 (2006
18. Bosco, D. A., et al. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat. Neurosci. 13, 1396-1403 (2010
19. Grad, L. I., et al. Intracellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and-independent mechanisms. Proc. Natl. Acad. Sci. USA 111, 3620-3625 (2014
20. Ayers, J. I., Fromholt, S. E., O?Neal, V. M., Diamond, J. H., & Borchlt, D. R. Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways. Acta Neurophathol. 131, 103-114 (2016
21. Bidhendi, E. E., et al. Two superoxide dismutase prion strains transmit amyotrophic lateral sclerosis-like disease. J. Clin. Invest doi: 10.1172/JCI84360 (2016
22. Shevde, L. A., Das, S., Clark, D. W., & Samant, R. S. Osteopontin: an effector and an effect of tumor metastasis. Curr. Mol. Med. 10, 71-81 (2010
23. Uede, T. Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases. Pathol. Int. 61, 265-280 (2011
24. Misawa, H., et al. Osteopontin is an alpha motor neuron marker in the mouse spinal cord. J. Neurosci. Res. 90, 732-742 (2012
25. von Neuhoff, N., et al. Monitoring CSF proteome alternations in amyotrophic lateral sclerosis: obstacles and perspectives in translating a novel marker panel to the clinic. PLoS One 7, e44401 (2012
26. Varghese, A. M., et al. Chitotriosidase-A putative biomarker for sporadic amyotrophic lateral sclerosis. Clin. Proteomics 10, 19 (2013
27. Lazar, M., et al. Involvement of osteopontin in the matrix-degrading and proangiogenic changes mediated by nicotine in pancreatic cancer cells. J. Gastrointest. Surg. 14, 1566-1577 (2010
28. Liu, H., Chen, A., Guo, F., & Yuan L. A shirt-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expression in prostate cancer PC-3 cells. Cancer Lett. 295, 27-37 (2010
29. Dahiya, S., et al. Osteopontin-stimulated expression of matrix metalloproteinase-9 causes cardiomyopathy in the mdx model of Duchenne muscular dystrophy. J. Immunol. 187, 2723-2731 (2011
30. Rangaswami, H., Bulbule, A., & Kundu, G. C. Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/I? Bα kinase-dependent nuclear factor ? B-mediated promatrix metalloproteinase-9 activation. J. Biol. Chem. 279, 38921-38935 (2004
31. Bendeck, M. P., et al. Smooth muscle cell matrix metalloproteinase production is stimulated via α vβ 3 integrin. Arterioscler. Thromb. Vasc. Biol. 20, 1467-1472 (2000
32. Kaplan, A., et al. Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration. Neuron 81, 333-348 (2014
33. Saxena, S., Cabuy, E., & Caroni, P. A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat. Neurosci. 12, 627-636 (2009
34. Walker, A. K., & Atkin, J. D. Stress signaling from the endoplasmic reticulum: A central player in the pathogenesis of amyotrophic lateral sclerosis. IUBMB Life 63, 754-763 (2011
35. Hadzipasic, M., et al. Selective degeneration of a physiological subtype of spinal motor neuron in mice with SOD1-linked ALS. Proc. Natl. Acad. Sci. USA 25, 16883-16888 (2014
36. Christensen, B., et al. Cell type-specific post-translational modifications of mouse osteopontin are associated with different adhesive properties. J. Biol. Chem. 282, 19463-19472 (2007
37. Nakamura, A., et al. Marked intrafamilial phenotypic variation in a family with SOD1 C111Y mutation. Amyotroph. Lateral Scler. 13, 479-486 (2012
38. Takei, Y., et al. α -Synuclein coaggregation in familial amyotrophic lateral sclerosis with SOD1 gene mutation. Hum. Pathol. 44, 1171-1176 (2013
39. Larsson, L., & Ansved, T. Effects of aging on the motor unit. Prog. Neurobiol. 45, 397-458 (1995
40. Liaw, L., et al. Altered wound healing in mice lacking a functional osteopontin gene (spp1). J. Clin. Invest. 101, 1468-1478 (1998
41. Mishina, M., et al. Molecular distinction between fetal and adult forms of muscle acetylcholine receptor. Nature 321, 406-411 (1986
42. Missias, A. C., Chu, G. C., Klocke, B. J., Sanes, J. R., & Merlie, J. P. Maturation of the acetylcholine receptor in skeletal muscle: regulation of the AChR ? -to-e switch. Dev. Biol. 179, 223-238 (1996
43. Denhardt, D. T., Noda, M., O?Regan, A. W., Pavlin, D., & Berman, J. S. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling and cell survival. J. Clin. Invest. 107, 1055-1061 (2001
44. Kahles, F., Findeisen, H. M., & Bruemmer, D. Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes. Mol. Metab. 3, 384-393 (2014
45. Anelli, T., et al. Acetylcholine induces neurite outgrowth and modulates matrix metalloproteinase 2 and 9. Biochem. Biophys. Res. Commun. 362, 267-274 (2007
46. Tsukita, S., et al. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J. Cell Biol. 126, 391-401 (1994
47. Pedraza, C. E., Nikolcheva, L. G., Kaartinen, M. T., Barralet, J. E., & McKee, M. D. Osteopontin functions as an opsonion and facilitates phagocytosis by macrophages of hydroxyapatite-coated microspheres: implications of bone wound healing. Bone 43, 708-716 (2008
48. Schack, L., et al. Osteopontin enhances phagocytosis through a novel osteopontin receptor, the α xβ 2 integrin. J. Immunol. 182, 6943-6950 (2009
49. Hegedus, J., Putman, C. T., Tyreman, N., & Gordon, T. Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis. J. Physiol. 586, 3337-3351 (2008
50. Park, K. H., Franciosi, S., & Leavitt, B. R. Postnatal muscle modification by myogenic factors modulates neuropathology and survival in an ALS mouse model. Nat. Commun. 4, 2906 (2013
51. Williams, A. H., et al. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 326, 1549-1554 (2009
52. Cortes, C. J., et al. Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy. Neuron 82, 295-307 (2014
53. Delbono, O. Neural control of aging skeletal muscle. Aging Cell 2, 21-29 (2003
54. Vandervoort, A. A. Aging of the human neuromuscular system. Muscle Nerve 25, 17-25 (2002
55. Valdez, G., Tapia, J. C., Lichtman, J. W., Fox, M. A., & Sanes, J. R. Shared resistance to aging and ALS in neuromuscular junctions of specific muscles. PLoS One 7, e34640 (2012
56. Del Río, P., et al. GDNF-induced osteopontin from Müller glial cells promotes photoreceptor survival in the Pde6brd1 mouse model of retinal degeneration. Glia 59, 821-832 (2011
57. Duan, X., et al. Subtype-specific regeneration of retinal ganglion cells following axotomy: effects of osteopontin and mTOR signaling. Neuron 85, 1244-1256 (2015
58. Hashimoto, M., Sun, D., Rittling, S. R., Denhardt, D. T., & Young, W. Osteopontin-deficient mice exhibit less inflammation, greater tissue damage, and impaired locomotor recovery from spinal cord injury compared with wild-type controls. J. Neurosci. 27, 3603-3611 (2007
59. Wright, M. C., et al. Novel roles for osteopontin and clusterin in peripheral motor and sensory axon regeneration. J. Neurosci. 34, 1689-1700 (2014
60. Vandenbroucke, R. E., & Libert, C. Is there new hope for therapeutic matrix metalloproteinase inhibition?. Nat. Rev. Drug Discov. 13, 904-927 (2014
61. Capote, J., et al. Osteopontin ablation ameliorates muscular dystrophy by shifting macrophages to a pro-regenerative phenotype. J. Cell Biol. 213, 275-288 (2016
62. Yamanaka, K., et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 11, 251-253 (2008
63. Heiman-Patterson, T. D., et al. Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS. J. Neurol. Sci. 236, 1-7 (2005
64. Ichikawa, T., Ajiki, K., Matsuura, J., & Misawa, H. Localization of two cholinergic markers, choline acetyltrasnferase and vesicular acetylcholine transporter in the central nervous system of the rat: in situ hybridization histochemistry and immunohistochemistry. J. Chem. Neuroanat. 13, 23-39 (1997
65. Misawa, H., Takahashi, R., & Deguchi, T. Calcium-independent release of acetylcholine from stable cell lines expressing mouse choline acetyltransferase cDNA. J. Neurochem. 62, 465-470 (1994